The problem of poor patient adherence has been extensively researched, but the rates of nonadherence have not changed much in the past 3 decades. Healthcare providers play a unique and important role ...

Even after the introduction of ETI for cystic fibrosis, habit continues to have a key role in adherence to inhaled medicines in patients with CF.

The largest ever UK trial of a urine test used across the NHS to spot when patients skip their medication has shown it may ...

Rates of nonadherence vary widely in the literature and can be very high, even in the tightly controlled environment of a clinical trial. Multiple factors contribute to nonadherence. For instance, ...

In this database analysis, greater adherence was observed for once-daily dosing compared with twice-daily dosing with chronic-use prescription medications used by ...

Aji Barot proposes that market access as a function of pharma is absolutely critical to the commercial success of a medicine. This involves engaging the relevant stakeholders, not just payers, at the ...

Physician-level medication adherence is a strong predictor of patient health and should be considered as a measure of physician quality. Objectives: To assess the extent to which medication adherence ...

The importance of comprehending patients' ever-evolving needs throughout their healthcare journey cannot be emphasized enough. It is not sufficient to merely recognise these needs; addressing them ...

Anyone who's worked in healthcare for a substantial length of their career is familiar with the "Triple Aim for Healthcare Improvement," first published in 2008 by then CEO of the Institute for ...

Please provide your email address to receive an email when new articles are posted on . Researchers assessed patients receiving omalizumab, dupilumab, mepolizumab, benralizumab, reslizumab or ...